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Almost one and a half centuries have passed 
since  Robert  Koch  and  Thomas  Burrill 
made the seminal discovery that bacteria 
are responsible for mammalian and plant 
diseases.  Shortly  after,  it  was  found  that 
parasites, fungi, and viruses are also etio-
logical agents of diseases in multi-cellular 
eukaryotes. As we roam the earth, we realize 
that we are outnumbered by the microbial 
community; that each of us has a micro-
biota which exceeds in numbers our own 
cells; and that the microbiota are essen-
tial components of our development and 
health. Another milestone was set by Robin 
Warren and Barry Marshall who discovered 
that a bacterium is responsible for gastric 
ulcer and gastric carcinoma, which earned 
them the 2005 Nobel Prize in Medicine, and 
changed our views and perspectives of other 
diseases. It opened the door to the possibil-
ity that microorganisms may be responsible 
for many other diseases of unknown etiol-
ogy, such as Alzheimer’s, gastrointestinal 
diseases of unknown etiology, and cardio-
vascular diseases.
The past few decades have witnessed 
a  quantum  leap  in  our  knowledge  of 
microbe–host interactions. This has been 
fueled by the discovery of the polymerase 
chain reaction (PCR), the determination 
of a large number of genomic sequences, 
advancements in cell biology and immu-
nology, and the development of various 
high  throughput  arrays  for  transcrip-
tome and proteome analyses. As genomic 
sequencing has become more feasible, our 
understanding  of  pathogenic  evolution 
and patho-adaptation to the host made 
tremendous strides. It is becoming clear 
that several of the specialized secretion sys-
tems are evolutionarily related to phages, 
and  that  phages  may  be  an  even  more 
important driving force in the evolution 
of virulence than previously appreciated. 
In addition, novel approaches have been 
utilized to identify a myriad of microbial 
effectors that are delivered to targets in the 
host cell by elaborate type III–VII trans-
location devices leading to modulation of 
various cellular processes (Holland, 2010). 
The advances in genetic manipulations of 
eukaryotic cells, along with the develop-
ment of various genetically defined animal 
models, have had and will continue to have 
tremendous impact on our knowledge of 
host–microbe  interactions.  Recent  years 
have  witnessed  major  progress  in  our 
understanding  of  innate  immunity  to 
infection, but we need to further expand 
our understanding of adaptive immunity, 
which has been lagging. Still, our progress 
in understanding host–microbe interac-
tions has been nothing less than remark-
able.  Having  said  that,  it  is  also  quite 
fascinating how little this has helped in 
generating new vaccines for various infec-
tious microbes or developing new thera-
pies against multi-drug resistant bacteria. 
It is also astonishing how few viral infec-
tions have effective therapeutic agents or 
vaccines. This dichotomy clearly indicates 
that, although our excitement and hyper-
ventilation about the new advances is well 
justified, we are only grasping the tip of 
the iceberg of host–microbe interactions, 
and our combined excitement and denial 
of  this  shallow  understanding  of  host–
microbe interactions keeps convincing us 
otherwise! There are numerous questions 
to be answered, as we dig deeper using the 
molecular  reductionist  approach,  where 
the focus has switched from the big picture 
of the disease to the study of microbe–host 
interaction at the molecular level.
Acknowledging  these  limitations, 
the “Grand Challenges” are put forth to 
encourage coordinated efforts to accom-
plish high impact goals that we currently 
think are unachievable. Setting targets for 
ourselves is essential for our ultimate aspi-
ration of generating knowledge and plat-
forms integrated across many biomedical 
disciplines that will benefit public health 
throughout  the  world.  The  challenges 
that  Frontiers  in  Cellular  and  Infection 
Microbiology  faces  are  highly  intercon-
nected, and overlap with those of many 
other biomedical disciplines.
Host–microbe interactions
Our recent advances led us to a more in-
depth understanding of host–microbe inter-
actions, and have fostered dominance of the 
reductionist approach. Molecular reduction-
ism is an extremely powerful approach, but 
to be strengthened and expanded, it must 
be combined with a focused approach to 
capture the big picture of diseases. We face 
major challenges to develop more appropri-
ate animal models that more reliably predict 
the course and outcome of human infec-
tious diseases. As we develop these, we must 
keep in mind that the models we use are 
animal models, which may not be extrapo-
lated accurately to the human host. The big 
interdisciplinary  challenge  to  biomedical 
sciences is to create computational virtual 
human and mouse model systems that are 
experiment-based,  high-precision,  multi-
scaled, and comprehensive (Kitano, 2010). 
Virtual human and animal model systems 
will be the “tool” that is needed for many 
biomedical and non-biomedical disciplines, 
including systems biology, biophysics, and 
infection and immunity. The development 
of these virtual models will allow simula-
tion and prediction of the consequences of 
host–microbe interactions, and translation 
of  these  interactions  from  a  molecular-
based reductionist approach to a host-based 
knowledge of the big picture of diseases. The 
consolidation  and  integration  of  isolated 
novel and seminal findings is as important 
as the findings themselves, because without 
this integration the grand challenge will not 
be met. Taken together, one of our major 
challenges  is  to  combine  the  molecular 
reductionist approach with the big picture 
of diseases, and analyze molecular interac-
tions in living cells and in animal models at 
the ultra-structural level.
select agents
As our understanding of molecular and cel-
lular aspects of host–microbe interactions 
has advanced, so has the potential misuse 
of microorganisms to destroy communities 
and societies. This has generated interest Frontiers in Microbiology  |  Cellular and Infection Microbiology    September 2010  | Volume 1  | Article 3  |  2
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cell and the microbe. Understanding the 
  molecular details involved in this   cross-talk 
will continue to challenge us, but our inno-
vations will overcome every obstacle that 
may hinder our progress in seeking this 
and other knowledge. Understanding the 
molecular details that trigger translocation 
of effectors will facilitate the development 
of therapeutic and preventive measures to 
target the translocation machineries, and 
block the signals that trigger them. This may 
have the potential of a common counter-
measure against various pathogens.
gastrointestinal microbiota
Understanding  how  the  magic  balance 
between  the  gastrointestinal  microbiota 
influences human health, disease and the 
variability between individuals will be one 
of the most challenging tasks, which will go 
far beyond understanding mechanisms of 
microbial pathogenesis in infectious diseases 
(Garrett et al., 2010). We are challenged to 
understand the imbalance of the gut microbi-
ota (dysbiosis) and the detailed nature of this 
imbalance, which is believed to be the etiol-
ogy of many modern diseases that are invad-
ing the developed world at lightning speed. 
These diseases include, but are not limited to, 
asthma, food allergies, Crohn’s disease and 
irritable bowel syndrome (Huffnagle, 2010). 
The consequences of short and long term use 
of antibiotics, and their short and long term 
effects on the gut microbiota, require detailed 
studies. The challenges to decipher the com-
plexity of the gut microbiota are enormous, 
considering  individual  variations,  which 
could result in significant consequences that 
may be underestimated. There is no doubt 
that the next few decades will reveal remark-
able findings related to the skin, oral, vaginal, 
nasal, and gut microbiota, which will benefit 
public health tremendously. The use of pro-
biotics, prebiotics, and neutraceuticals has 
become widespread without any in-depth 
understanding of their use. The high com-
plexity of the gut microbiota will continue to 
challenge us for decades, since most of them 
are uncultured.
moving UncUltUred organisms to 
tHe cUltUred commUnity
Another grand challenge is to develop cul-
ture media to add the uncultured microbi-
ota and the obligate intracellular bacteria to 
the cultured community of microbes. The 
recent development of a growth medium for 
bacterial proliferation within mammalian 
macrophages and amoeba, and for intrapul-
monary proliferation of Legionella in the 
mouse model of the disease. Remarkably, 
both eukaryotic machineries are exploited 
by the same injected effector, Ankyrin B, 
most of which is composed of four eukaryo-
tic motifs: two ankyrin repeats, an F-box 
domain,  and  a  C-terminus  “CaaX”  far-
nesylation motif (Price et al., 2009, 2010). 
Studies on genetic acquisition and evolution 
of this and other microbial eukaryotic-like 
proteins in bacterial effectors that are spe-
cifically recognized by bacterial chaperones 
and injected into the host cell by specialized 
type III-VII secretion machineries should 
yield interesting insights into host–microbe 
adaptation and pathogenic evolution. As 
advances in structural biology and other 
disciplines  continue,  resolving  structural 
aspects of the microbial effectors and their 
injections through the translocation appa-
ratuses, along with the sequential molecular 
interactions during the injection process, 
will  be  a  challenge.  However,  we  should 
be able to tackle that challenge in the near 
future, particularly with continued advances 
in related disciplines.
For  injected  bacterial  effectors,  deci-
phering  the  evolution  of  structural  and 
functional  mimicry  of  eukaryotic  post-
translational modification motifs, such as 
the Fic motif for AMPylation and the CaaX 
motif for farnesylation (Broberg and Orth, 
2010; Price et al., 2010), will require further 
advances in our bioinformatical analyses. 
Our study of the role of inter-kingdom hor-
izontal gene transfer and convergent evo-
lution in the acquisition of eukaryotic-like 
proteins and motifs requires improvements 
in computational models to decipher the 
mechanism of this genetic evolution. The 
recent achievements of a functional syn-
thetic microbial genome by Craig Venter 
and  his  co-workers  will  soon  become  a 
standard tool that will speed up our progress 
and understanding of microbial evolution 
as well as host–microbe interaction.
Although,  our  approaches  to  iden-
tify injected bacterial effectors have been 
innovative, the signals that trigger translo-
cation of the effectors are still unknown. 
We  do  understand  that  pathogens  sense 
their attachment to the host cell to trig-
ger translocation, but the process is most 
likely more complex at the molecular level 
and requires cross-talk between the host 
in developing therapeutic and   preventive 
measures to select agents. It would be wise 
to first acquire the basic knowledge of the 
biology  and  pathogenesis  of  the  select 
agents; otherwise, our efforts to develop 
rapid therapeutic and preventive measures 
may be misguided.
evolUtion of fUnctional and 
strUctUral mimicry of eUkaryotic 
Proteins in PatHogenic 
microorganisms
It is becoming evident that many patho-
genic microorganisms have co-evolved in 
the  environment  with  other  prokaryotic 
and primitive eukaryotic organisms. One 
of the grand challenges is to continue the 
study of the evolutionary aspects of patho-
genic microorganisms and to identify and 
develop as models lower eukaryotic hosts 
that likely contributed to the evolution of 
pathogenicity  in  many  microorganisms. 
The  development  of  these  less  complex 
model hosts will require detailed studies 
to understand the biology of these hosts. 
Deciphering the interaction of pathogenic 
microorganisms with their environmental 
primitive hosts should thus be an integral 
component of our studies with the multi-
cellular  mammalian  and  plant  hosts.  A 
myriad of effectors injected by microbial 
pathogens into the host cell seem to have 
eukaryotic structural and functional simi-
larities, such as Ankyrin repeat-containing 
proteins, GTPase, SNAREs, and F-box pro-
teins (Price et al., 2009; Al-Khodor et al., 
2010). Therefore, understanding the genetic 
acquisition of these eukaryotic-like proteins 
will be essential for our understanding of 
pathogenic evolution and host adaptation 
of microbes.
For example, the interaction of Legionella 
with protozoa and other primitive eukary-
otes has most likely been a major factor 
in  evolving  its  ability  to  infect  humans 
(Molmeret et al., 2005). Co-evolution with 
protozoa  has  shaped  pathogenic  evolu-
tion of Legionella to exploit evolutionar-
ily  conserved  eukaryotic  processes  that 
have facilitated pulmonary infection of the 
human host. Examples of these conserved 
eukaryotic processes exploited by Legionella 
in evolutionarily distant hosts are the polyu-
biquitination (Price et al., 2009) and far-
nesylation machineries (Price et al., 2010). 
Interestingly, exploitation of both eukaryo-
tic machineries is essential for intracellular www.frontiersin.org  September 2010  | Volume 1  | Article 3  |  3
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biological processes. Since the grand chal-
lenges that many biomedical disciplines face 
are interlinked and unmistakably overlap, 
developments in other fields, such as syn-
thetic chemistry and biophysics of imaging, 
will continue to benefit and advance our 
progress in cellular and infection microbiol-
ogy and host–microbe interaction.
The  grand  challenges  encountered 
by the post-omic era is to integrate the 
molecular  reductionist  approach  and 
the powerful information obtained from 
in  vitro  studies  into  a  comprehensive 
understanding of the big picture of the 
disease in vivo. The time is ripe to rein-
vigorate Koch’s postulate, and integrate it 
into our reductionist molecular approach 
to provide a more in-depth knowledge of 
disease in the host.
To deal with the tremendous advances in 
research and its global expansion, innova-
tions in the communication of research find-
ings are continuing to evolve. While other 
journals think open access is the future for 
scientific publishing, the Frontiers Research 
Foundation believes that it is needed now, 
which will lead us to a more innovative 
future in scientific publishing and, there-
fore, the foundation has positioned itself 
at the forefront of innovation of academic 
publishing.
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Coxiella by Robert Heinzen and colleagues 
(Omsland et al., 2009) is a beautiful exam-
ple of the combination of post-genomic 
analyses,  basic  bacterial  metabolism  and 
physiology to formulate the composition 
of the medium to grow, what was known 
as an obligate intracellular bacterium. This 
is a seminal achievement that will definitely 
enhance the development of genetic tools 
to dissect various aspects of microbe–host 
interaction, and it certainly provides many 
glimpses of hope that we will succeed in 
culturing other obligate intracellular as well 
as extracellular yet uncultured bacteria.
wireless microbial 
commUnication
The  discovery  of  wireless  bacterial  social 
communication through quorum sensing 
in  the  marine  bacterium  Vibrio  fischeri, 
which started in the 1960s, has led to a new 
paradigm in infectious diseases and host–
microbe  interactions  (Miller  and  Bassler, 
2001). The identification of the chemical 
structure of the inducer by Oppenheimer 
and colleagues (Eberhard et al., 1981) has 
opened wide the doors to understand the 
biochemical and genetic bases of microbial 
communication.  These  seminal  discover-
ies, pioneered by many experts including 
Barbara  Iglewski,  Peter  Greenberg,  and 
Bonnie Bassler, have changed our thoughts 
and perspectives of infectious diseases and 
microbial ecology. The cross-species com-
munication through quorum sensing during 
infections of the oral, GI, or vaginal tract will 
continue to evolve, but understanding this 
cross-species communication is challenged 
by the complexity of the respective microbi-
ota. Understanding the complexity of these 
systems will take time, and is tightly linked to 
developments in other related disciplines.
moving forward
Undoubtedly,  biomedical  sciences  must 
continue to expand and strengthen their 
interdisciplinary  approach  to  decipher 